Yeah, nearly added Wed but BO was in for 5.50. They didn't push it that low and it's been UP nicely since then. That should continue until Jan 24.
Last month and last week, I increased my position over 60% in the low $4s. I didn't have the powder to do so at those attractive lower levels. I tried again this week, but order didn't fill, as most 'sells' were measly 100 lameazz HFT lots.
So - WHEN will any of the 'good news' posters keep finding get us out of the clutches of the WS criminals? No matter what is done, said, reported, PRd, etc. - we remain in bondage. I've added twice in the last 3 weeks and wanted to again today at $3.75, to keep averaging down.
I have a BO in under $8 to add to my position.
sahm - you are dead on. Shorts have had their way with Arena (ARNA) since FDA approval 6/2012. At that time Retail was ~80% and a LT poster said until that is flipped around, the MM, HF, etc. the stock will be manipulated. He was right. We are close to 50/50 now. If you want to learn about the power, tools, etc. these criminals have, look at the chart since 6/2012, look at posts by Evil Joe a few months ago detailing their methods, etc.
Gary - do you feel this also means they will push us down to $4 or a bit less? We've been stuck at $4.15ish most of the day. Have a BO in at $4.10 to keep averaging down.
Luk - agree overall but the launch was too conservative, mgmt selling and not buying, not promoting diabetes benefit, mgmt not doing anything to drive off shorts, no new countries, phen/smoking still in process has hurt us since approval. they need to start doing things for us and SP.
You have been here a loooong time, but don't post as often, like many of us LT longs that have been frustrated with the SP and sales. We keep hanging on for the payday.
BY - good synopsis. They are testing Belviq for other indications and developing a pipeline, so RD expenses remain high. Sales have not met expectations, yet the steady growth, at times over 10% week over week, have not moved the sp. Now, compare Arena to VVUS and OREX - both weight loss focused - but the latter ones favored by WS. V has tanked, but still goes up on good news. O has been pumped all year and they were the third player in the obesity space. WS bet heavy against Arena, was 80% retail owned at approval, so they have attacked to bring down the price, run off retail and make their money on the short game. Ownership is around 50/50 now and long ago it was stated that until our original 80/20 was reversed, we'd be manipulated. I didn't believe that then, but did after a year or so. Hard lesson.
LOOK BACK longer and you will see a range well above .30-.60 even after the Avian Flu spike. I got in in early 2012 due to the tech, added more in 2013 @.42, sold the 2012 holdings at $1.75 on 10/10, which I regretted when it ran over $3. I'm holding the 2013 position for a $3-5 sale if we are involved in a contract. Regardless, I believe this plant process is the future. Low cost, faster production, high quality.
Sentiment: Strong Buy
BV - I have lived this with Arena. Approved 6/2012, delayed DEA scheduling 1/2013, shorts have ruled us and ran us down from $13 on 6/2012 to as low as 3.26 recently. It was a gradual walk down, some ups, but trend has been down and stagnant in the $4 range for a long time. Sales continue to grow, pipeline advancing, etc. but all good news is smothered by hit pieces, most often from the Street of course. Unless sales are on a steep incline with RMTI, meeting or exceeding expectations, we may be in for a similar situation.
My CB has been $53 for a few years. Despite robber/gwo repeated claims here about the infamous bagholders, that IS my CB - splits and all. Period. I will consider selling some at that SP. If we reach $60, I would likely sell it all.
Part 4 - 6th try
Also I have to believe this manipulation has to involve collusion between all the major players in the Herbalife short attack since it wouldn't work like it has if they didn't work together. If one or more of the major short players decided they didn't want to participate further in driving the share price down, and decided to buy to cover, this would create a major problem for those other major short players. The remaining major short players would not only have to drive the price down based on selling shares to new longs but would also have to sell shares to those other major short players buying to cover their shorts. The remaining short players would not be able to manipulate the stock share price as easy as they did working together.
If you are wondering why would they short more shares even when a company like Herbalife is obviously a healthy growing company. Here is the reason. Since the shorts already have the investment community wondering about problems, introduced by the shorts themselves, concerning the company; since shorts have already shorted $745 Million+ (12,422,168 X $60 per share (my guess at average share price shorts sold their shares at)) shares of Herbalife; and by just adding almost $32 Million (585,409 X $54 average-?) more shares shorted, the shorts were able to take the steam out of a lot of the longs' enthusiasm over the 2nd quarter financial news, and now the shorts believe they will have a better opportunity to buy to cover their shorts at a lower price as well as they will have more time to do so. At least that's what the shorts hope for.
Turning blind eye. Bribed, kickbacks, stock tips, blackmailed or just plain lazy Feds.
Mick - don't like what you say here, but it's likely true. They pushed us down prior to approval and again right after. WS criminals took control, as usual. Regulators need to do their job and ensure a fair and transparent market.